vs
Side-by-side financial comparison of Atlanta Braves Holdings, Inc. (BATRA) and SBC Medical Group Holdings Inc (SBC). Click either name above to swap in a different company.
Atlanta Braves Holdings, Inc. is the larger business by last-quarter revenue ($61.3M vs $39.6M, roughly 1.5× SBC Medical Group Holdings Inc). SBC Medical Group Holdings Inc runs the higher net margin — 35.9% vs -67.6%, a 103.5% gap on every dollar of revenue. On growth, Atlanta Braves Holdings, Inc. posted the faster year-over-year revenue change (17.6% vs -10.9%). Over the past eight quarters, SBC Medical Group Holdings Inc's revenue compounded faster (-15.0% CAGR vs -52.5%).
Atlanta Braves Holdings, Inc. is a sports and entertainment holding company that owns and operates the Atlanta Braves MLB franchise. It also manages adjacent mixed-use real estate, live events, merchandise sales, and media operations, serving fans across the U.S. Southeast and global baseball audiences.
SBC Medical Group Holdings Inc. is a leading Japan-headquartered healthcare provider primarily focused on aesthetic medicine, dermatology, and anti-aging wellness services. It operates an extensive network of clinics across Japan, catering to both domestic patients and international medical tourists, with core offerings including cosmetic surgery and non-invasive skincare treatments.
BATRA vs SBC — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $61.3M | $39.6M |
| Net Profit | $-41.4M | $14.2M |
| Gross Margin | — | 73.1% |
| Operating Margin | -81.2% | 32.5% |
| Net Margin | -67.6% | 35.9% |
| Revenue YoY | 17.6% | -10.9% |
| Net Profit YoY | -116.7% | 117.2% |
| EPS (diluted) | $-0.64 | $0.15 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $61.3M | $39.6M | ||
| Q3 25 | $311.5M | $43.4M | ||
| Q2 25 | $312.4M | $43.4M | ||
| Q1 25 | $47.2M | $47.3M | ||
| Q4 24 | $52.1M | $44.4M | ||
| Q3 24 | $290.7M | $53.1M | ||
| Q2 24 | $282.9M | $53.1M | ||
| Q1 24 | — | $54.8M |
| Q4 25 | $-41.4M | $14.2M | ||
| Q3 25 | $30.0M | $12.8M | ||
| Q2 25 | $29.5M | $2.5M | ||
| Q1 25 | $-41.4M | $21.5M | ||
| Q4 24 | $-19.1M | $6.5M | ||
| Q3 24 | $10.0M | $2.8M | ||
| Q2 24 | $29.1M | $18.5M | ||
| Q1 24 | — | $18.8M |
| Q4 25 | — | 73.1% | ||
| Q3 25 | — | 70.6% | ||
| Q2 25 | — | 69.2% | ||
| Q1 25 | — | 79.7% | ||
| Q4 24 | — | 76.3% | ||
| Q3 24 | — | 81.5% | ||
| Q2 24 | — | 74.2% | ||
| Q1 24 | — | 72.1% |
| Q4 25 | -81.2% | 32.5% | ||
| Q3 25 | 12.5% | 36.6% | ||
| Q2 25 | 13.4% | 33.6% | ||
| Q1 25 | -94.2% | 51.1% | ||
| Q4 24 | -35.8% | 10.6% | ||
| Q3 24 | 2.2% | 26.1% | ||
| Q2 24 | 8.8% | 51.4% | ||
| Q1 24 | — | 44.6% |
| Q4 25 | -67.6% | 35.9% | ||
| Q3 25 | 9.6% | 29.6% | ||
| Q2 25 | 9.4% | 5.7% | ||
| Q1 25 | -87.7% | 45.4% | ||
| Q4 24 | -36.7% | 14.7% | ||
| Q3 24 | 3.4% | 5.3% | ||
| Q2 24 | 10.3% | 34.8% | ||
| Q1 24 | — | 34.2% |
| Q4 25 | $-0.64 | $0.15 | ||
| Q3 25 | $0.47 | $0.12 | ||
| Q2 25 | $0.46 | $0.02 | ||
| Q1 25 | $-0.66 | $0.21 | ||
| Q4 24 | $-0.29 | $0.05 | ||
| Q3 24 | $0.16 | $0.03 | ||
| Q2 24 | $0.46 | $0.20 | ||
| Q1 24 | — | $0.20 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $99.9M | $164.1M |
| Total DebtLower is stronger | $738.6M | $42.8M |
| Stockholders' EquityBook value | $526.0M | $248.3M |
| Total Assets | $1.6B | $380.4M |
| Debt / EquityLower = less leverage | 1.40× | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $99.9M | $164.1M | ||
| Q3 25 | $82.2M | $127.4M | ||
| Q2 25 | $96.2M | $152.7M | ||
| Q1 25 | $244.7M | $132.1M | ||
| Q4 24 | $110.1M | $125.0M | ||
| Q3 24 | $100.9M | $137.4M | ||
| Q2 24 | $121.2M | — | ||
| Q1 24 | — | — |
| Q4 25 | $738.6M | $42.8M | ||
| Q3 25 | $759.9M | $21.1M | ||
| Q2 25 | $703.1M | $7.1M | ||
| Q1 25 | $699.5M | $6.9M | ||
| Q4 24 | $617.1M | $6.6M | ||
| Q3 24 | $640.1M | $823.2K | ||
| Q2 24 | $600.0M | — | ||
| Q1 24 | — | — |
| Q4 25 | $526.0M | $248.3M | ||
| Q3 25 | $560.3M | $248.0M | ||
| Q2 25 | $522.8M | $244.6M | ||
| Q1 25 | $486.1M | $226.4M | ||
| Q4 24 | $524.2M | $195.1M | ||
| Q3 24 | $530.4M | $205.0M | ||
| Q2 24 | $512.7M | $8.8M | ||
| Q1 24 | — | $9.0M |
| Q4 25 | $1.6B | $380.4M | ||
| Q3 25 | $1.7B | $321.4M | ||
| Q2 25 | $1.7B | $315.3M | ||
| Q1 25 | $1.7B | $284.6M | ||
| Q4 24 | $1.5B | $266.1M | ||
| Q3 24 | $1.6B | $296.5M | ||
| Q2 24 | $1.6B | $19.5M | ||
| Q1 24 | — | $19.8M |
| Q4 25 | 1.40× | 0.17× | ||
| Q3 25 | 1.36× | 0.09× | ||
| Q2 25 | 1.34× | 0.03× | ||
| Q1 25 | 1.44× | 0.03× | ||
| Q4 24 | 1.18× | 0.03× | ||
| Q3 24 | 1.21× | 0.00× | ||
| Q2 24 | 1.17× | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $26.4M | $52.0M |
| Free Cash FlowOCF − Capex | — | $51.2M |
| FCF MarginFCF / Revenue | — | 129.3% |
| Capex IntensityCapex / Revenue | 0.0% | 2.0% |
| Cash ConversionOCF / Net Profit | — | 3.66× |
| TTM Free Cash FlowTrailing 4 quarters | — | $23.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $26.4M | $52.0M | ||
| Q3 25 | $-88.8M | $-20.9M | ||
| Q2 25 | $-8.1M | $-8.3M | ||
| Q1 25 | $95.8M | $1.9M | ||
| Q4 24 | $28.9M | $-7.3M | ||
| Q3 24 | $-69.0M | $5.0M | ||
| Q2 24 | $-34.3M | $19.2M | ||
| Q1 24 | — | $3.7M |
| Q4 25 | — | $51.2M | ||
| Q3 25 | — | $-20.9M | ||
| Q2 25 | $-82.3M | $-8.6M | ||
| Q1 25 | $76.3M | $1.7M | ||
| Q4 24 | $16.8M | $-7.9M | ||
| Q3 24 | $-85.5M | $4.6M | ||
| Q2 24 | $-64.1M | $18.3M | ||
| Q1 24 | — | $3.0M |
| Q4 25 | — | 129.3% | ||
| Q3 25 | — | -48.3% | ||
| Q2 25 | -26.3% | -19.9% | ||
| Q1 25 | 161.5% | 3.5% | ||
| Q4 24 | 32.3% | -17.8% | ||
| Q3 24 | -29.4% | 8.7% | ||
| Q2 24 | -22.7% | 34.5% | ||
| Q1 24 | — | 5.4% |
| Q4 25 | 0.0% | 2.0% | ||
| Q3 25 | 0.0% | 0.1% | ||
| Q2 25 | 23.7% | 0.7% | ||
| Q1 25 | 41.3% | 0.5% | ||
| Q4 24 | 23.2% | 1.3% | ||
| Q3 24 | 5.7% | 0.8% | ||
| Q2 24 | 10.5% | 1.6% | ||
| Q1 24 | — | 1.3% |
| Q4 25 | — | 3.66× | ||
| Q3 25 | -2.96× | -1.63× | ||
| Q2 25 | -0.28× | -3.39× | ||
| Q1 25 | — | 0.09× | ||
| Q4 24 | — | -1.12× | ||
| Q3 24 | -6.89× | 1.77× | ||
| Q2 24 | -1.18× | 1.04× | ||
| Q1 24 | — | 0.20× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BATRA
| Baseball | $34.8M | 57% |
| Mixed Use Development Segment | $26.5M | 43% |
SBC
| Franchising | $10.3M | 26% |
| Medical Corporation Shobikai | $8.1M | 21% |
| Medical Corporation Nasukai | $7.2M | 18% |
| Management Services | $6.3M | 16% |
| Rental Services | $4.3M | 11% |
| Medical Corporation Association Furinkai | $3.0M | 8% |
| Japan Medical And Beauty Inc | $656.5K | 2% |
